Functional characterization of NPM1–TYK2 fusion oncogene
Open Access
- 18 January 2022
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 6 (1) , 1-10
Abstract
Gene fusions are known to drive many human cancers. Therefore, the functional characterization of newly discovered fusions is critical to understanding the oncobiology of these tumors and to enable therapeutic development. NPM1–TYK2 is a novel fusion identified in CD30 + lymphoproliferative disorders, and here we present the functional evaluation of this fusion gene as an oncogene. The chimeric protein consists of the amino-terminus of nucleophosmin 1 (NPM1) and the carboxyl-terminus of tyrosine kinase 2 (TYK2), including the kinase domain. Using in vitro lymphoid cell transformation assays and in vivo tumorigenic xenograft models we present direct evidence that the fusion gene is an oncogene. NPM1 fusion partner provides the critical homodimerization needed for the fusion kinase constitutive activation and downstream signaling that are responsible for cell transformation. As a result, our studies identify NPM1–TYK2 as a novel fusion oncogene and suggest that inhibition of fusion homodimerization could be a precision therapeutic approach in cutaneous T-cell lymphoma patients expressing this chimera.Keywords
This publication has 44 references indexed in Scilit:
- Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug DevelopmentToxicological Research, 2014
- Origin of Chromosomal Translocations in Lymphoid CancerCell, 2010
- Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implicationsLeukemia, 2009
- Anchorage-independent cell growth signature identifies tumors with metastatic potentialOncogene, 2009
- Anaplastic lymphoma kinase: signalling in development and diseaseBiochemical Journal, 2009
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Establishment of a mouse xenograft model for mycosis fungoidesExperimental Dermatology, 2004
- Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicityBlood, 2003
- Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastomaProceedings of the National Academy of Sciences, 2003
- Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.Proceedings of the National Academy of Sciences, 1995